Stock PRN PROFOUND MEDICAL CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Company Profound Medical Corp.

Equities

PRN

CA74319B5027

Advanced Medical Equipment & Technology

Market Closed - Toronto S.E.
Other stock markets
 03:59:47 2024-04-18 pm EDT 		5-day change 1st Jan Change
10.54 CAD -1.40% Intraday chart for Profound Medical Corp. -5.39% -5.05%
Mar. 13 Transcript : Profound Medical Corp. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 11:15 AM
Mar. 11 Alliance Global Partners Trims Price Target on Profound Medical to $10.80 From $12.75, Maintains Buy Rating MT

Business Summary

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO is designed to provide customizable and predictable radiation-free ablation of a surgeon-defined prostate volume while protecting the urethra and rectum. TULSA-PRO has the potential to be a flexible technology in customizable prostate ablation, including intermediate stage cancer, localized radio-recurrent cancer, retention and hematuria palliation in locally advanced prostate cancer and the transition zone in large volume benign prostatic hyperplasia. It is also commercializing Sonalleve, which is a therapeutic platform for the treatment of uterine fibroids and palliative pain treatment of bone metastases.

Number of employees: 131

Sales per Business

CAD in Million2022Weight2023Weight Delta
Recurring - Non-Capital
94.5 %
6 70.0 % 9 94.5 % +50.87%
Capital Equipment
5.5 %
3 30.0 % 1 5.5 % -79.67%

Sales per region

CAD in Million2022Weight2023Weight Delta
United States
71.2 %
4 50.8 % 7 71.2 % +56.53%
Germany
25.6 %
2 26.9 % 2 25.6 % +6.39%
Canada
3.2 %
2 22.3 % 0 3.2 % -84.00%

Managers

Managers TitleAgeSince
Arun Menawat CEO
 Chief Executive Officer 69 15-06-03
Rashed Dewan DFI
 Director of Finance/CFO 56 15-06-30
Mathieu Burtnyk COO
 Chief Operating Officer 42 11-07-06
Stephen Kilmer IRC
 Investor Relations Contact - -
Abbey Goodman PRN
 Corporate Officer/Principal 41 -
Hartmut Warnken PRN
 Corporate Officer/Principal - 15-11-01
Jacques Fernand Cornet PRN
 Corporate Officer/Principal 67 -

Members of the board

Members of the board TitleAgeSince
Arthur Rosenthal BRD
 Director/Board Member 77 18-06-13
Brian Robert Ellacott BRD
 Director/Board Member 67 18-06-13
Cynthia Lavoie BRD
 Director/Board Member - 21-03-02
Arun Menawat CEO
 Chief Executive Officer 69 15-06-03
Kris Shah BRD
 Director/Board Member 63 22-05-17
Murielle Lortie BRD
 Director/Board Member 54 20-11-29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 24,428,899 22,300,605 ( 91.29 %) 0 91.29 %

Shareholders

NameEquities%Valuation
Gagnon Securities LLC
9.028 %
2,205,324 9.028 % 19 M $
Gagnon Securities LLC
6.310 %
1,541,576 6.310 % 13 M $
Fidelity Investments Canada ULC
4.915 %
1,200,635 4.915 % 10 M $
Fidelity Investments Canada ULC
4.915 %
1,200,635 4.915 % 10 M $
Letko, Brosseau & Associates Inc.
4.822 %
1,177,850 4.822 % 10 M $
Letko Brosseau Investment Management, Inc.
4.822 %
1,177,850 4.822 % 10 M $
Don Daseke
4.523 %
1,105,000 4.523 % 9 M $
Gagnon Advisors LLC
2.781 %
679,296 2.781 % 6 M $
Gagnon Advisors LLC
2.654 %
648,465 2.654 % 6 M $
AIGH Capital Management LLC
2.647 %
646,733 2.647 % 6 M $

Company contact information

Profound Medical Corp.

2400 Skymark Avenue Unit 6

L4W 5K5, Mississauga

+

http://www.profoundmedical.com
address Profound Medical Corp.(PRN)

Sector

Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Advanced Medical Equipment & Technology
Other Advanced Medical Equipment & Technology

Sales per Business

Sales per region

Ratings for Profound Medical Corp.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
10.54 CAD
Average target price
12.5 CAD
Spread / Average Target
+18.60%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
PROFOUND MEDICAL CORP. Stock Profound Medical Corp.
-5.05% 189M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+2.02% 209B
DANAHER CORPORATION Stock Danaher Corporation
+2.17% 177B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+10.45% 133B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+16.62% 99.89B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
-2.70% 61.83B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.38% 52.51B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-6.33% 45.54B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-4.74% 39.43B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+9.89% 38.87B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. PRN Stock
  4. Company Profound Medical Corp.